Viridian Therapeutics: Q1 Earnings Insights

Viridian Therapeutics VRDN reported its Q1 earnings results on Thursday, May 12, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.


Viridian Therapeutics beat estimated earnings by 9.26%, reporting an EPS of $-0.98 versus an estimate of $-1.08.

Revenue was down $1.24 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.42 which was followed by a 5.46% increase in the share price the next day.

To track all earnings releases for Viridian Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!